Shay Shemesh - Net Worth and Insider Trading
Shay Shemesh Net Worth
The estimated net worth of Shay Shemesh is at least $13 Million dollars as of 2024-11-07. Shay Shemesh is the Chief Dev. & Ops. Officer of Nuvectis Pharma Inc and owns about 1,493,068 shares of Nuvectis Pharma Inc (NVCT) stock worth over $13 Million. Details can be seen in Shay Shemesh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shay Shemesh has not made any transactions after 2024-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shay Shemesh
Shay Shemesh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shay Shemesh owns 1 companies in total, including Nuvectis Pharma Inc (NVCT) .
Click here to see the complete history of Shay Shemesh’s form 4 insider trades.
Insider Ownership Summary of Shay Shemesh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVCT | Nuvectis Pharma Inc | 2024-05-10 | Chief Development Officer |
Shay Shemesh Latest Holdings Summary
Shay Shemesh currently owns a total of 1 stock. Shay Shemesh owns 1,493,068 shares of Nuvectis Pharma Inc (NVCT) as of May 10, 2024, with a value of $13 Million.
Latest Holdings of Shay Shemesh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVCT | Nuvectis Pharma Inc | 2024-05-10 | 1,493,068 | 8.52 | 12,723,328 |
Holding Weightings of Shay Shemesh
Shay Shemesh Form 4 Trading Tracker
According to the SEC Form 4 filings, Shay Shemesh has made a total of 10 transactions in Nuvectis Pharma Inc (NVCT) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in Nuvectis Pharma Inc is the acquisition of 1,113 shares on May 10, 2024, which cost Shay Shemesh around $7,034.
Insider Trading History of Shay Shemesh
- 1
Shay Shemesh Trading Performance
GuruFocus tracks the stock performance after each of Shay Shemesh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shay Shemesh is 16.04%. GuruFocus also compares Shay Shemesh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shay Shemesh within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shay Shemesh's insider trading performs compared to the benchmark.
Performance of Shay Shemesh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.95 | | | | | |
| Relative Return to S&P 500(%) | -7.16 | | | | | |
Shay Shemesh Ownership Network
Ownership Network List of Shay Shemesh
Ownership Network Relation of Shay Shemesh
Shay Shemesh Owned Company Details
What does Nuvectis Pharma Inc do?
Who are the key executives at Nuvectis Pharma Inc?
Shay Shemesh is the Chief Development Officer of Nuvectis Pharma Inc. Other key executives at Nuvectis Pharma Inc include director & Chairman & CEO Ron Bentsur , Chief Science and Business Off Enrique Poradosu , and 10 percent owner Marlio Charles Mosseri .
Nuvectis Pharma Inc (NVCT) Insider Trades Summary
Over the past 18 months, Shay Shemesh made 1 insider transaction in Nuvectis Pharma Inc (NVCT) with a net purchase of 1,113. Other recent insider transactions involving Nuvectis Pharma Inc (NVCT) include a net purchase of 18,095 shares made by Ron Bentsur , a net purchase of 202,124 shares made by Marlio Charles Mosseri , and a net purchase of 500 shares made by Enrique Poradosu .
In summary, during the past 3 months, insiders sold 0 shares of Nuvectis Pharma Inc (NVCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nuvectis Pharma Inc (NVCT) were sold and 221,832 shares were bought by its insiders, resulting in a net purchase of 221,832 shares.
Nuvectis Pharma Inc (NVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nuvectis Pharma Inc Insider Transactions
Shay Shemesh Mailing Address
Above is the net worth, insider trading, and ownership report for Shay Shemesh. You might contact Shay Shemesh via mailing address: C/o Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275, Fort Lee Nj 07024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
